Complex Coding Requirements
Molecular pathology CPT codes (81200–81479), NGS panels (81445–81455), and PCR tests (87635) often confuse.
SALSA-ready RCM with DEX Z-Code mapping, audit-proof documentation, and 98% clean claim rates for molecular diagnostics and genetic testing labs.
Serving molecular labs, genetic labs, and hospital labs with expert-driven billing, compliance, and automation.
Molecular labs face unique billing challenges that lead to high denial rates, revenue leakage, and compliance risks:
Errors in PCR, NGS, and hereditary cancer panel billing
Missing or incorrect DEX Z-Codes and PLA codes
Inefficient workflows slowing reimbursements
Compliance risks with evolving payer policies (CLIA, CMS, OIG, CAP)
Prior authorization and payer-specific coverage gaps
Facing any of these issues? Let’s discuss.
Billing for molecular diagnostics and genetic testing labs comes with unique challenges that can slow revenue, increase denials, and create compliance risks:
Complex Coding Requirements
Molecular pathology CPT codes (81200–81479), NGS panels (81445–81455), and PCR tests (87635) often confuse.
DEX Z-Code™ Gaps
Failure to map CPT codes to unique 5-character DEX Z-Code™ identifiers (required by MolDX, UnitedHealthcare, and other payers in 2026) can result in automatic denials on facility and professional claims.
Frequent denials
Common denial codes include CO-50, CO-97, PR-96, and CO-16, often due to missing prior authorization or documentation gaps.
Compliance requirements
Adhering to CLIA, CMS, OIG, and CAP standards is mandatory.
Prior authorization & payer-specific rules
Navigating coverage policies for NGS, PCR, and genetic tests can be complex.
Delayed reimbursements & high A/R
Inefficient RCM workflows lead to lost revenue and administrative burden.
We provide comprehensive, compliance-driven molecular diagnostics reimbursement solutions, covering all aspects of laboratory billing:
Service 01
Full-Cycle Molecular Lab RCM
Clean claim submission for NGS, PCR, and genetic testing with automated status tracking, denial prevention, and payer follow-up.
Service 02
CPT, PLA & Molecular Coding Accuracy
Expert handling of PLA codes vs CPT, molecular pathology codes, NGS panels, and PCR testing aligned to payer rules and medical necessity standards.
Service 03
Eligibility Verification & Prior Authorization
Real-time benefit checks and authorization workflows to prevent denials before testing is performed.
Service 04
Denial Management & Appeals
Root-cause denial analysis, payer-specific appeals, and documentation defense for high-value molecular claims.
Service 05
A/R Management & Financial Reporting
Reduced A/R days (20–30 average) with transparent reporting on collections, denials, and payer performance.
MolDX, administered by Palmetto GBA across multiple MAC regions, governs Medicare coverage for molecular diagnostics. Every test requires:
Technology Assessment documentation
DEX Z-Code registry enrollment and mapping
LCD coverage verification
Audit-ready documentation for clean claims
Verify LCD/NCD status before testing
Generate HIPAA-compliant ABNs within 24 hours
Protect your lab from non-covered claim write-offs
BRCA1/2 (81162–81163), Lynch syndrome (81292–81317), multi-gene panels (81432–81435)
Ensure prior authorization, family history documentation, and payer compliance
BRCA1/2 (81162–81163), Lynch syndrome (81292–81317), multi-gene panels (81432–81435)
Manage payer-specific documentation, prior authorization, and patient cost workflows
Protect against Medicare CLFS cuts
CLIA, CMS, OIG, CAP alignment
LDT documentation defense
Continuous updates for LCD/NCD changes
Smart Claim Scrubbing
AI identifies errors and gaps before submission, preventing denials.
Automated Denial Analysis
Trend detection flags Z-Code mismatches, LCD issues, and NGS panel conflicts.
Faster Revenue Cycle
Intelligent automation accelerates claims processing and approvals.
Compliance First
AI continuously cross-checks claims against CLIA, CMS, and payer policies.
Real-Time Insights
Dashboard reporting delivers instant visibility into claim status and revenue metrics.
Maximize revenue, reduce denials, and ensure compliance with AI-driven billing tailored for molecular labs.
Our solutions are flexible and customizable to suit your lab’s specialty and workflow:
Molecular Diagnostics & Genomics Labs
PCR, NGS, and advanced molecular tests
Genetic Testing & Hereditary Disease Labs
BRCA, Lynch, multi-gene panels
Molecular Pathology & Oncology Labs
Tumor profiling, liquid biopsies, precision oncology
PCR & NGS Specialty Labs
Next-generation sequencing and specialty assays
Reference & Multi-State Clinical Labs
Labs operating across multiple locations and states
Immunology & Cytogenetics Labs
Complex immunoassays, chromosome analysis
Clinical Molecular Labs & Biotechnology Research Labs
Research and translational testing
Toxicology & Biological Labs
Pharmacology, safety, and bioanalytics
Anatomic Pathology Labs
Molecular-histopathology integration
Pharmacogenomics Labs
Multi-gene PGx panels and personalized medicine
Split billing for physician office labs vs reference labs: We manage technical vs professional component claims separately with proper modifiers and payer compliance.
AI-powered + human-verified billing
Deep expertise in molecular diagnostics billing
Dedicated billing specialists
Real-time reporting
Compliance-first approach
Choosing the right partner directly impacts your lab’s financial performance. Look for:
Proven experience with MolDX programs
DEX Z-Code registry and mapping expertise
SALSA reporting readiness
Integration with LIS systems like Epic Beaker, Sunquest, and LabWare
DEX Z-Codes are unique identifiers required by MolDX and many commercial payers for molecular claims. Each test must be mapped correctly to a Z-Code, or claims will be denied. We manage registry enrollment and mapping for your full test menu.
SALSA replaces PAMA reporting and helps stabilize Medicare reimbursement rates. Labs that fail to comply may experience revenue loss. We manage compliant data reporting to protect your lab’s revenue.
NGS panels are billed as a single code, while molecular pathology tests are billed individually. Incorrect billing leads to denials. We determine the correct approach based on payer rules.
Most commercial payers require prior authorization for genetic and NGS tests. Medicare relies on LCD coverage instead. We verify all requirements before testing begins.
Medicare requires coverage determination, physician order, MolDX documentation, and correct Z-Code mapping. Missing any of these leads to denial. We validate all claims before submission.
Accelerate payments and streamline your molecular lab billing with Dastify Solutions.